October 25, 2003 - Volume 25 - Issue 20
pp: 4-71



Survey: Public Unaware of Threatened Medicare Cancer Cuts

Erikson, Jane

Oncology Times. 25(20):5-6, October 25, 2003.

Once informed of the provisions in the reform legislation that would slash payments for care, those interviewed for an ASCO and NCCS survey said they would prefer no Medicare reform to changes that undermine patients' access to treatment.

New Medicines in Development for Cancer, Part 4

Oncology Times. 25(20):51-52,55-56,61, October 25, 2003.

Part 4 of the latest Pharmaceutical Research and Manufacturers of America survey showing the nearly 400 cancer-related medicines in the pipeline.


Congress Mounts Campaign to Improve Pain Control

Eastman, Peggy

Oncology Times. 25(20):6-8, October 25, 2003.

The National Pain Care Policy Act of 2003 (HR 1863) calls for $60 million to improve pain care and training in the US, creating a new NIH center for pain research and six regional pain centers and other innovations.


Tidal Wave of Bureaucracy Poised to Swamp European Research, Conference Told

Smith, Michael

Oncology Times. 25(20):20,23, October 25, 2003.

News of note from the European Cancer Conference: Docetaxel is apparent winner in first head-to-head comparison with paclitaxel, but toxicity much greater; first gold-standard NSCLC comparison trial proves adjuvant chemo extends survival; Richard Peto's assessment that fewer men are dying of prostate cancer, thanks to hormone therapy; and the tidal wave of paperwork predicted to swamp European research.


Testicular Cancer Largely Curable With Current Treatment Options

Goodman, Alice

Oncology Times. 25(20):29-32,37, October 25, 2003.

A current overview of the management of testicular cancer, including discussion of the key role of serum markers, surveillance vs retroperitoneal lymph node dissection, and the differing views about radiation therapy.


‘THE COMMON THREAD: A Story of Science, Politics, Ethics, and the Human Genome’

Durant, John R.

Oncology Times. 25(20):43-44, October 25, 2003.

Reviews of the story behind the science, politics, and ethics of the human genome; and the case against assisted suicide.




1 2 3 4 5